NCT04150913 2025-11-25
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
Massachusetts General Hospital
Phase 2 Completed
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
University Hospital, Montpellier
Cancer Research UK
Federal University of São Paulo